BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ourlin JC, Handschin C, Kaufmann M, Meyer UA. A Link between cholesterol levels and phenobarbital induction of cytochromes P450. Biochem Biophys Res Commun. 2002;291:378-384. [PMID: 11846416 DOI: 10.1006/bbrc.2002.6464] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Kocarek TA, Mercer-Haines NA. Squalestatin 1-inducible expression of rat CYP2B: evidence that an endogenous isoprenoid is an activator of the constitutive androstane receptor. Mol Pharmacol 2002;62:1177-86. [PMID: 12391282 DOI: 10.1124/mol.62.5.1177] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 2.2] [Reference Citation Analysis]
2 Režen T. The impact of cholesterol and its metabolites on drug metabolism. Expert Opin Drug Metab Toxicol 2011;7:387-98. [PMID: 21320036 DOI: 10.1517/17425255.2011.558083] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
3 Meyer RP, Lindberg RL, Hoffmann F, Meyer UA. Cytosolic persistence of mouse brain CYP1A1 in chronic heme deficiency. Biological Chemistry 2005;386. [DOI: 10.1515/bc.2005.132] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
4 Suter L, Haiker M, de Vera MC, Albertini S. Effect of two 5-HT6 receptor antagonists on the rat liver: a molecular approach. Pharmacogenomics J 2003;3:320-34. [DOI: 10.1038/sj.tpj.6500207] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
5 Handschin C, Podvinec M, Amherd R, Looser R, Ourlin JC, Meyer UA. Cholesterol and bile acids regulate xenosensor signaling in drug-mediated induction of cytochromes P450. J Biol Chem 2002;277:29561-7. [PMID: 12045201 DOI: 10.1074/jbc.M202739200] [Cited by in Crossref: 45] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
6 Lühe A, Suter L, Ruepp S, Singer T, Weiser T, Albertini S. Toxicogenomics in the pharmaceutical industry: Hollow promises or real benefit? Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2005;575:102-15. [DOI: 10.1016/j.mrfmmm.2005.02.009] [Cited by in Crossref: 52] [Cited by in F6Publishing: 33] [Article Influence: 3.3] [Reference Citation Analysis]
7 Handschin C, Gnerre C, Fraser DJ, Martinez-Jimenez C, Jover R, Meyer UA. Species-specific mechanisms for cholesterol 7alpha-hydroxylase (CYP7A1) regulation by drugs and bile acids. Arch Biochem Biophys 2005;434:75-85. [PMID: 15629111 DOI: 10.1016/j.abb.2004.10.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
8 Ahmadi Y, Karimian R, Panahi Y. Effects of statins on the chemoresistance-The antagonistic drug-drug interactions versus the anti-cancer effects. Biomed Pharmacother. 2018;108:1856-1865. [PMID: 30372891 DOI: 10.1016/j.biopha.2018.09.122] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
9 Zhang LL, Zhang JR, Yu ZG, Zhao J, Mo F, Jiang SX. Effects of ionophores on liver CYP1A and 3A in male broilers: Effects of ionophores on CYP in broilers. Journal of Veterinary Pharmacology and Therapeutics 2010;33:551-7. [DOI: 10.1111/j.1365-2885.2010.01168.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
10 Roth A, Boess F, Landes C, Steiner G, Freichel C, Plancher J, Raab S, de Vera Mudry C, Weiser T, Suter L. Gene expression-based in vivo and in vitro prediction of liver toxicity allows compound selection at an early stage of drug development. J Biochem Mol Toxicol 2011;25:183-94. [DOI: 10.1002/jbt.20375] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
11 Yang LQ, Yu WF, Cao YF, Gong B, Chang Q, Yang GS. Potential inhibition of cytochrome P450 3A4 by propofol in human primary hepatocytes. World J Gastroenterol 2003; 9(9): 1959-1962 [PMID: 12970884 DOI: 10.3748/wjg.v9.i9.1959] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
12 Miyata K, Koga T, Aso S, Hoshuyama S, Ajimi S, Furukawa K. A subchronic (180-day) oral toxicity study of ethyl tertiary-butyl ether, a bioethanol, in rats. Drug Chem Toxicol 2014;37:303-10. [PMID: 24252074 DOI: 10.3109/01480545.2013.851690] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
13 Yang LQ, Li SJ, Cao YF, Man XB, Yu WF, Wang HY, Wu MC. Different alterations of cytochrome P450 3A4 isoform and its gene expression in livers of patients with chronic liver diseases. World J Gastroenterol 2003; 9(2): 359-363 [PMID: 12532467 DOI: 10.3748/wjg.v9.i2.359] [Cited by in CrossRef: 47] [Cited by in F6Publishing: 42] [Article Influence: 2.6] [Reference Citation Analysis]
14 Oscarson M, Burk O, Winter S, Schwab M, Wolbold R, Dippon J, Eichelbaum M, Meyer UA. Effects of rifampicin on global gene expression in human small intestine. Pharmacogenetics and Genomics 2007;17:907-18. [DOI: 10.1097/fpc.0b013e3280143dfc] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
15 Handschin C, Meyer UA. Regulatory network of lipid-sensing nuclear receptors: roles for CAR, PXR, LXR, and FXR. Archives of Biochemistry and Biophysics 2005;433:387-96. [DOI: 10.1016/j.abb.2004.08.030] [Cited by in Crossref: 123] [Cited by in F6Publishing: 114] [Article Influence: 7.7] [Reference Citation Analysis]
16 Handschin C, Meyer UA. Induction of Drug Metabolism: The Role of Nuclear Receptors. Pharmacol Rev 2003;55:649-73. [DOI: 10.1124/pr.55.4.2] [Cited by in Crossref: 323] [Cited by in F6Publishing: 270] [Article Influence: 17.9] [Reference Citation Analysis]